Alembic Pharma receives USFDA’s final approval for Fesoterodine Fumarate extended-release… EP News Bureau Jan 9, 2023 The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Toviaz Extended-Release tablets, 4 mg…
Alembic Pharma receives US FDA tentative approval for Fesoterodine Fumarate extended-release tablets EP News Bureau Feb 2, 2022 The tentatively approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Toviaz extended-release…
